SEC Form 4 · accession 0001140361-17-029089
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stark Richard
Officer — SVP, GM - Oncology
Period of report
Jul 22, 2017
Accepted (ET)
Jul 28, 2017 · 3:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 22, 2017 | F | 393 | $16.80 | D | 18,040 | D | |
| Common StockF2 | Jul 25, 2017 | F | 432 | $17.12 | D | 17,608 | D | |
| Common StockF3 | Jul 26, 2017 | A | 3,648 | $0.00 | A | 21,256 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $16.55 | Jul 26, 2017 | A | 12,818 | A | Jul 26, 2018 | Jul 26, 2027 | Common Stock | 12,818 | 12,818 | D |
| Performance RightF5 | — | Jul 26, 2017 | A | 7,296 | A | — | — | Common Stock | 7,296 | 7,296 | D |
Explanation of responses
- F1The exempt disposition of 393 shares of common stock ("Common Stock") of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 22, 2015.
- F2The exempt disposition of 432 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 25, 2014.
- F3This acquisition of 3,648 shares of Common Stock represents 3,648 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021.
- F4These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021.
- F5Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.